IFNA1 and peeling skin syndrome: An increased expression of type I IFN-inducible genes (ISGs), due to the dysregulation of IFN signaling pathways, called the ‘IFN signature’, has been observed in the salivary glands and peripheral blood of approximately 50% of pSS patients (15, 16) and correlates with disease severity (17, 18).